Ovation Science’s Hand Sanitizer DermSafe Now Manufactured in Canada

Ovation Science (CSE OVAT)
Published on: August 19, 2020

New Inventory of Pharmaceutical-Grade Hand Sanitizer Now Available

Vancouver, BC – August 19, 2020 (CSE: OVAT) – Ovation Science Inc. (“Ovation” or the “Company”) announces that it has expanded its production of its DermSafe® Hand Sanitizer Lotion by completing the manufacturing of its first order in Canada at a contract manufacturer in Ontario that follows strict cGMP guidelines set by Health Canada.

Additionally, the Company is pleased to announce that it is now working with 5 distributors across Canada, with a strong focus on industries that can benefit from the use of DermSafe, including schools, independent retailers, sports facilities and private airlines amongst others.

“We having been successful manufacturing DermSafe through our existing channels in the USA however expanding our capacity to our Canadian contract manufacturer will improve availability and reduce delivery costs for our customers. We are pleased to have this additional source of inventory to supplement our current supply as we expand our reach across Canada and continue to meet the needs of the growing market,” said Mr. Terry Howlett, President of Ovation. “People are purchasing DermSafe because they want an alternative to the drying effects of alcohol-based hand sanitizers. They also want to not only stay protected themselves but also to help employees feel more comfortable coming back to work or for students going back to school or university.” He added, “There are two sizes of DermSafe available, a 59ml personal sized bottle which is easy to carry in your pocket or purse, as well as a commercial use 236ml bottle with a precise pump that can sit on a counter at home or at the office.”

Facts About DermSafe Hand Sanitizer That Makes It Different:

  • DermSafe is listed by Health Canada as an approved product under: “Disinfectants and hand sanitizers accepted under COVID-19 interim measure.
  • DermSafe has two Drug Identification Numbers (DIN) for personal use and personal commercial use.
  • DermSafe has received the “Dermatology Seal of Approval” from the Canadian Dermatology Review Panel.
  • DermSafe is a pharmaceutical-grade hand sanitizer lotion backed by science.
  • It is made without alcohol therefore it is non-drying. Instead DermSafe offers the persistent protection of chlorhexidine gluconate; an ingredient used worldwide as a pre-surgical soap due to its proven abilities to kill germs.
  • DermSafe uses a proprietary polymer delivery system called Invisicare®, which enhances how products stay on the skin and how it delivers drugs to the skin.

Statements have not been evaluated by Health Canada. These products are not intended to diagnose, treat, cure, or prevent any disease.

For information about DermSafe and to purchase visithttps://dermsafe.com

For information about Ovation Science products visithttps://ovationscience.com/products/.

About Ovation Science Inc.

Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including DermSafe, all made with patented Invisicare® skin delivery technology. The technology enhances the delivery of ingredients to and through the skin and is protected by patents in eleven countries. With over twenty years of topical and transdermal drug delivery experience in the pharmaceutical market, Ovation’s management and science team have created a unique pipeline of over twenty-five patent-protected medical / wellness topical and transdermal products along with a line of anti-aging / beauty formulas. Ovation earns revenues from licensing and development fees, royalties, the sale of Invisicare to its licensees and now revenue from its own product sales. Ovation has offices in Vancouver, BC Canada and Las Vegas, Nevada, USA. Ovation trades on the CSE under the symbolOVAT. Visit our website www.ovationscience.com.

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In particular there is no assurance of sales online or through distributors. There are no guarantees of future performance. Ovation Science Inc. cautions that all forward looking statements are inherently uncertain and that actual results may be affected by a number of material factors, many of which are beyond Ovation Science Inc.’s control. Accordingly, readers should not place undue reliance on the forward-looking information. Ovation disclaims any obligation to revise or update any such forward-looking information to reflect future results, events or circumstances, except as required by law.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Contact:

FOR INVESTOR RELATIONS:

Sebastian Kunyz: [email protected]  Phone 604-684-6730 or 866-684-6730

FOR BUSINESS DEVELOPMENT & CORPORATE INQUIRIES:

Doreen McMorran: [email protected]  Phone:  604.283.0903 ext. 4

Biotechnology COVID-19 Life Science Pharmaceutical